Eslam Mohamed, PharmBS, PhD

Eslam Mohamed, PharmBS,  PhD

Adjunct Associate Professor

Phone: (916) 686-9275


Dr. Hazem Ali is Adjunct Associate Professor at California Northstate University. Dr. Ali received Bachelor of Pharmacy from Mansoura University, Egypt and Ph.D. in Pharmaceutics from University of Louisiana at Monroe, Monroe, LA, USA. His Ph.D. research focused on formulation development and physicochemical characterization of self-emulsifying Drug Delivery Systems (SEDDS) and Nanoparticles. He used statistical modeling and experimental design (Design-of-Experiments (DoE)) to develop Simvastatin/Tocotrienol lipid nanoparticles and studied their effect on breast cancer cell lines. After graduation, Dr. Ali joined University of Texas Medical Branch at Galveston, Texas, USA as Postdoctoral Fellow where he developed polymeric nanoparticles and studied their transport across in vitro models of human placenta and Blood Brain Barrier (BBB). He designed Oxcarbazepine-loaded polymeric nanoparticles for potential therapy of Pregnant Women with Epilepsy. Dr. Ali was awarded William and Mary McGanity Research Fund Award for his research. Subsequently, Dr. Ali joined Moores Cancer Center at the University of California San Diego, San Diego, CA, USA where his research was supported by Ruth L. Kirschtein T32 Postdoctoral Fellowship from NIH. He was trained to develop enzyme-encapsulated silica nanoparticles and study their effects on nude mice bearing ovarian tumor xenografts. Dr. Ali is currently a Chemist in the Office of Pharmaceutical Quality at the US FDA Center for Drug Evaluation and Research.


The role of cholesterol and lipid metabolism in myeloid cells undergoing inflammation. Tumor cells vulnerabilities to stress responses and chemotherapy.